Clinical Trial Update: Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating lycopene for patients undergoing radical prostatectomy for prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Drugs mentioned

• Lycopene (lycopene)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Stage I Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-07-16